Insider · CIK 0001635075

Ramaswamy Vivek

Reports to the SEC for 5 companies · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001635075

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-15	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+832K sh	$12.68	+$10.6M	34,486,208
2025-12-15	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−354K sh	$22.05	−$7.8M	34,132,463
2025-12-15	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−479K sh	$22.05	−$10.6M	33,653,755
2025-12-15	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−832K sh	—	—	22,150,227
2025-12-12	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+4.67M sh	$12.68	+$59.3M	38,326,479
2025-12-12	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−1.98M sh	$21.96	−$43.4M	36,350,621
2025-12-12	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−2.7M sh	$21.96	−$59.2M	33,653,755
2025-12-12	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−4.67M sh	—	—	22,982,680
2025-12-11	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+1.87M sh	$12.68	+$23.7M	35,523,447
2025-12-11	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−774K sh	$21.64	−$16.8M	34,749,305
2025-12-11	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−1.1M sh	$21.64	−$23.7M	33,653,755
2025-12-11	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)M Exercise/Conversion	10% Owner	MExercise/Conversion	−1.87M sh	—	—	27,655,404
2025-11-17	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−540K sh	$20.51	−$11.1M	33,653,756
2025-11-14	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−1.03M sh	$20.33	−$20.9M	34,193,406
2025-11-13	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−287K sh	$20.81	−$5.98M	35,221,076
2025-11-05	ASSTStrive, Inc.P Purchase	10% Owner	PPurchase	+15.6K sh	$80.00	+$1.25M	15,625
2025-09-05	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−386K sh	$12.96	−$5M	35,508,359
2025-09-04	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−195K sh	$12.92	−$2.52M	35,894,175
2025-09-03	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−1.2M sh	$12.50	−$14.9M	36,089,108
2025-06-20	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−577K sh	$11.46	−$6.61M	37,284,108
2025-06-18	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−565K sh	$11.45	−$6.47M	37,861,115
2025-06-06	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−201K sh	$11.19	−$2.25M	38,426,381
2025-06-04	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−547K sh	$11.34	−$6.21M	38,627,181
2025-05-07	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−625K sh	$11.18	−$6.99M	39,174,611
2025-05-06	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−274K sh	$11.47	−$3.14M	39,799,611
2025-01-23	ROIVRoivant Sciences Ltd.G Gift	10% Owner	GGift	−13.4M sh	—	—	40,073,570
2025-01-23	ROIVRoivant Sciences Ltd.G Gift	10% Owner	GGift	+13.4M sh	—	—	13,357,857
2024-01-02	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−3M sh	$11.05	−$33.2M	51,929,426
2023-12-27	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+275K sh	—	—	55,063,337
2023-12-27	ROIVRoivant Sciences Ltd.F Tax Payment	10% Owner	FTax Payment	−134K sh	$11.58	−$1.55M	54,929,426
2023-12-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−611K sh	$6.40	−$3.91M	7,132,921
2023-12-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−252K sh	$11.50	−$2.89M	11,570,769
2023-09-28	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−61.9K sh	$12.67	−$785K	54,788,110
2023-09-27	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+120K sh	—	—	54,850,057
2023-09-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−204K sh	$6.40	−$1.3M	7,744,314
2023-09-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−252K sh	$11.50	−$2.89M	11,822,307
2023-08-28	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−47.7K sh	$11.25	−$537K	54,730,523
2023-08-27	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+86.7K sh	—	—	54,778,215
2023-08-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−204K sh	$6.40	−$1.3M	7,948,112
2023-07-31	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−76K sh	$11.43	−$869K	54,691,501
2023-07-27	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+166K sh	—	—	54,767,524
2023-07-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−408K sh	$6.40	−$2.61M	8,151,910
2023-05-31	ROIVRoivant Sciences Ltd.J Other	10% Owner	JOther	−190K sh	$9.09	−$1.73M	54,601,467
2023-05-27	ROIVRoivant Sciences Ltd.M Exercise/Conversion	10% Owner	MExercise/Conversion	+382K sh	—	—	54,791,414
2023-05-27	ROIVRoivant Sciences Ltd. · Capped Value Appreciation RightsM Exercise/Conversion	10% Owner	MExercise/Conversion	−1.22M sh	$6.40	−$7.83M	8,559,505
2023-02-22	ROIVRoivant Sciences Ltd.S Sale	10% Owner	SSale	−4M sh	$7.95	−$31.8M	54,409,211
2018-06-19	ABUSArbutus Biopharma Corp · Director Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2017-06-21	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2016-06-03	ABUSArbutus Biopharma Corp · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2016-04-29	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Director, Principal Executive Officer, 10% Owner	AAward	+357K sh	—	—	357,000

Recent filings

Accepted (ET)
Dec 154
Ramaswamy Vivek0001635075-25-000006
SEC(opens sec.gov)
Nov 174
Ramaswamy Vivek0001635075-25-000005
SEC(opens sec.gov)
Nov 74
Ramaswamy Vivek0000950103-25-014486
SEC(opens sec.gov)
Sep 54
Ramaswamy Vivek0002007997-25-000007
SEC(opens sec.gov)
Jun 234
Ramaswamy Vivek0002007997-25-000006
SEC(opens sec.gov)

Companies

Address

C/O STEVE ROBERTS 700 PENNSYLVANIA AVE., SE STE. 440

WASHINGTON, DC, 20003